IL6 and lymphoma: Tim-3+ ECs modulate the T cell response to lymphoma surrogate antigens by inhibiting CD4+ T cell activation and Th1 polarization in an IL-6-STAT3-dependent way, thus promoting lymphoma onset, growth, and dissemination 47.